The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis.
Journal Information
Full Title: Dis Markers
Abbreviation: Dis Markers
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of Interest The authors declare that they have no conflicts of interest."
Funding Disclosure
Evidence found in paper:
"This work was supported by the Mechanism of PD-1/PD-L1 Signaling Pathway in Pulmonary Tuberculosis-Promoting Lung Cancer Cell Transformation. Grant number: 2022SF-580."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025